Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies

Cell Mol Immunol. 2021 Apr;18(4):1061-1063. doi: 10.1038/s41423-021-00648-1. Epub 2021 Feb 25.

¹ Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
² Yong-Chuan Hospital, Chongqing Medical University, Chongqing, China.
³ Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, China.
⁴ Yong-Chuan Hospital, Chongqing Medical University, Chongqing, China. [email protected].
⁵ Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. [email protected].
⁶ Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. [email protected].

^# Contributed equally.

No abstract available

Publication types